SimonMed Imaging Partners with Lunit for AI Breast Cancer Detection
SimonMed Imaging has partnered with Lunit to enhance breast cancer detection using advanced AI technology, announced in a press release. This collaboration will integrate Lunit INSIGHT DBT, combined with Volpara Analytics, into SimonMed's Personalized Breast Cancer Detection service across its network of over 170 centers in the United States.
The AI solution, trained on millions of images, is designed to detect subtle signs of breast cancer, improving both sensitivity and specificity. This integration aims to provide patients with a precise, personalized, and data-driven screening experience, supported by SimonMed's team of over 200 subspecialty-trained radiologists.
Dr. Sean Raj, Chief Innovation Officer at SimonMed Imaging, emphasized the importance of this partnership in offering the most advanced mammogram experience available today. The initiative reflects SimonMed's commitment to early detection and proactive patient care.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
LUNGevity Awards $2 Million for Lung Nodule Risk Studies
Linearis Joins Two Canadian AI Health Data Projects
Brainomix and Pulmonary Fibrosis Foundation Partner on AI Lung Imaging Research
miRoncol Health Launches AI Cancer Screening Blood Test in Ontario
SimBioSys Gets FDA Clearance for AI Breast Cancer Recurrence Tool
Daily AI Brief: the AI news that matters, in your inbox.